Form 4 for MGNX MACROGENICS INC
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-28 · accession 0001125345-22-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-31 | 2022-10-28 | MGNX | Risser Eric Blasius | COO | M - OptEx | $1.51 | +8,500 | 53.5K | +19% | +$12.8K |
| D | 2022-10-31 | 2022-10-28 | MGNX | Risser Eric Blasius | COO | M - OptEx | $1.51 | -8,500 | 0 | -100% | -$12.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-28 | M | A | 8,500 | $1.51 | 53,468 | D | — | — | |
| 2 | Derivative | Employee stock option (right to buy) | 2022-10-28 | M | D | 8,500 | $1.51 | 0 | D | $1.51 · 2013-07-06 to 2023-01-05 | 8,500 Common Stock | (F1) 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |